| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.14 | 0.3 |